Corient Private Wealth LP Acquires 50,861 Shares of HCA Healthcare, Inc. $HCA

Corient Private Wealth LP boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 106.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 98,705 shares of the company's stock after purchasing an additional 50,861 shares during the quarter. Corient Private Wealth LP's holdings in HCA Healthcare were worth $38,485,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. California State Teachers Retirement System increased its holdings in HCA Healthcare by 38,348.7% in the 2nd quarter. California State Teachers Retirement System now owns 89,141,330 shares of the company's stock worth $34,755,313,000 after purchasing an additional 88,909,485 shares in the last quarter. BlackRock Inc. bought a new stake in shares of HCA Healthcare during the second quarter worth about $5,069,974,000. Norges Bank acquired a new stake in HCA Healthcare during the 4th quarter worth approximately $1,262,513,000. Legal & General Group Plc acquired a new position in HCA Healthcare in the 2nd quarter valued at approximately $410,992,000. Finally, Jupiter Topco LLC acquired a new position in shares of HCA Healthcare during the second quarter worth $371,138,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Up 0.1%

Shares of HCA stock opened at $427.51 on Monday. The firm has a market capitalization of $92.56 billion, a PE ratio of 14.31, a price-to-earnings-growth ratio of 1.40 and a beta of 1.10. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The firm has a fifty day simple moving average of $404.99 and a two-hundred day simple moving average of $432.69.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the previous year, the firm earned $6.84 EPS. The business's revenue for the quarter was up 8.7% compared to the same quarter last year. On average, equities analysts predict that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare's payout ratio is 10.45%.

Analysts Set New Price Targets

HCA has been the subject of several recent research reports. KeyCorp decreased their price target on HCA Healthcare from $475.00 to $435.00 and set an "overweight" rating for the company in a research note on Monday, July 27th. JPMorgan Chase & Co. decreased their target price on shares of HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating for the company in a research report on Thursday, August 20th. Truist Financial dropped their price target on shares of HCA Healthcare from $535.00 to $495.00 and set a "buy" rating on the stock in a research report on Monday, July 27th. Weiss Ratings reissued a "hold (c+)" rating on shares of HCA Healthcare in a research note on Friday, September 4th. Finally, TD Cowen decreased their price target on HCA Healthcare from $500.00 to $431.00 and set a "buy" rating for the company in a report on Monday, June 22nd. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $462.64.

About HCA Healthcare

HCA Healthcare, Inc NYSE: HCA is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.